| Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine R Buettner, C Morales, MH Chen, X Wu, LS Chen, DH Hoang, ... Journal of Hematology & Oncology 14 (1), 1-16, 2021 | 46 | 2021 |
| New Developments in Dual-Labeled Molecular Imaging Agents S Hernandez Vargas, SC Ghosh, A Azhdarinia Journal of Nuclear Medicine 60 (4), 459-465, 2019 | 37 | 2019 |
| Synthesis of a Fluorescently Labeled 68Ga-DOTA-TOC Analog for Somatostatin Receptor Targeting SC Ghosh, S Hernandez Vargas, M Rodriguez, S Kossatz, J Voss, ... ACS medicinal chemistry letters 8 (7), 720-725, 2017 | 36 | 2017 |
| Specific targeting of somatostatin receptor subtype-2 for fluorescence-guided surgery S Hernandez Vargas, S Kossatz, J Voss, SC Ghosh, HST Cao, J Simien, ... Clinical Cancer Research, clincanres. 3312.2018, 2019 | 29 | 2019 |
| Evaluation of anti-LGR5 antibodies by immunoPET for imaging colorectal tumors and development of antibody–drug conjugates A Azhdarinia, J Voss, SC Ghosh, JA Simien, S Hernandez Vargas, J Cui, ... Molecular Pharmaceutics 15 (6), 2448-2454, 2018 | 21 | 2018 |
| Receptor-targeted fluorescence-guided surgery with low molecular weight agents S Hernandez Vargas, C Lin, HS Tran Cao, N Ikoma, S AghaAmiri, ... Frontiers in Oncology 11, 2021 | 17 | 2021 |
| Targeted dual-modal PET/SPECT-NIR imaging: from building blocks and construction strategies to applications SM Usama, SC Marker, S Hernandez Vargas, S AghaAmiri, SC Ghosh, ... Cancers 14 (7), 1619, 2022 | 16 | 2022 |
| Arenicolins: C-Glycosylated Depsides from Penicillium arenicola B Perlatti, N Lan, CE Earp, S AghaAmiri, S Hernandez Vargas, ... Journal of Natural Products, 2020 | 16 | 2020 |
| Establishment of novel neuroendocrine carcinoma patient-derived xenograft models for receptor peptide-targeted therapy CG Tran, LC Borbon, JL Mudd, E Abusada, S AghaAmiri, SC Ghosh, ... Cancers 14 (8), 1910, 2022 | 13 | 2022 |
| High-contrast detection of somatostatin receptor subtype-2 for fluorescence-guided surgery S Hernandez Vargas, S AghaAmiri, SC Ghosh, MP Luciano, LC Borbon, ... Molecular pharmaceutics 19 (11), 4241-4253, 2022 | 12 | 2022 |
| Development of a drug–device combination for fluorescence-guided surgery in neuroendocrine tumors S Hernandez Vargas, C Lin, J Voss, SC Ghosh, DM Halperin, ... Journal of Biomedical Optics 25 (12), 126002, 2020 | 8 | 2020 |
| Comparison of HER2-targeted antibodies for fluorescence-guided surgery in breast cancer S AghaAmiri, J Simien, AM Thompson, J Voss, SC Ghosh, ... Molecular imaging 2021, 5540569, 2021 | 4 | 2021 |
| A proof-of-concept methodology to validate the in situ visualization of residual disease using cancer-targeted molecular agents in fluorescence-guided surgery S Hernandez Vargas, C Lin, S AghaAmiri, J Voss, N Ikoma, HST Cao, ... Molecular-Guided Surgery: Molecules, Devices, and Applications VI 11222, 112220P, 2020 | 4* | 2020 |
| Somatostatin receptor subtype-2 targeting system for specific delivery of temozolomide S AghaAmiri, SC Ghosh, S Hernandez Vargas, DM Halperin, ... Journal of Medicinal Chemistry 67 (4), 2425-2437, 2024 | 3 | 2024 |
| Translational potential of a contrast agent for FGS applications in pNETs S AghaAmiri, JS Estrella, SH Vargas, MW Hurd, SC Ghosh, A Azhdarinia, ... Molecular Imaging and Biology 26 (2), 191-194, 2024 | 2 | 2024 |
| SSTR2-targeted theranostics in hepatocellular carcinoma M Momeny, S AghaAmiri, S Hernandez Vargas, B Acidi, SC Ghosh, ... Cancers 17 (2), 162, 2025 | 1 | 2025 |
| Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Theranostic Applications M Momeny, SH Vargas, S AghaAmiri, JT Adams, TM Bateman, SC Ghosh, ... bioRxiv, 2025.01. 29.635283, 2025 | | 2025 |
| A simple and rapid in vitro assay for identification of direct inhibitors of O6-methylguanine-DNA methyltransferase V Khalaj, S AghaAmiri, SC Ghosh, SH Vargas, M Momeny, A Azhdarinia BioTechniques 76 (7), 343-351, 2024 | | 2024 |
| Tumor-selective delivery of the PARP inhibitor Rucaparib via small molecule drug conjugates to improve combination therapy with 177Lu-PSMA RLT BS Ludwig, R Wöhr, S Ghosh, SH Vargas, L Koller, S AghaAmiri, ... Journal of Nuclear Medicine 65 (supplement 2), 242175-242175, 2024 | | 2024 |
| DUSP6 is a novel target in neuroendocrine tumors M Momeny, V Khalaj, S AghaAmiri, PH Ear, SH Vargas, S Ghosh, ... Cancer Research 84 (6_Supplement), 5953-5953, 2024 | | 2024 |
Ali AzhdariniaAssociate Professor of Molecular Medicine, The University of Texas Health Science Center-Houstonכתובת אימייל מאומתת בדומיין uth.tmc.edu